New insider activity at Bio Green Med Solution ( (BGMS) ) has taken place on October 23, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Significant shareholder FITTERS Diversified Berhad has divested 92,352 shares of Bio Green Med Solution, generating a total of $277,056 from the transaction.
Recent Updates on BGMS stock
Bio Green Med Solution (BGMS) has experienced notable developments recently. On October 6, 2025, the company finalized an Asset Purchase Agreement with Tethra Biosciences Inc., selling certain assets, including patent rights related to Plogosertib, for $300,000 with a potential milestone payment of $170,000. This move signifies a strategic shift in operations by transferring key intellectual property. Additionally, on October 7, 2025, BGMS announced a quarterly cash dividend of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock, payable on November 1, 2025. Despite these developments, Spark, TipRanks’ AI Analyst, rates BGMS as Underperform due to the company’s financial strain, operational inefficiencies, and unattractive valuation metrics, such as a negative P/E ratio and lack of dividend yield. The technical sentiment signal remains a Strong Sell, reflecting ongoing market skepticism.
Spark’s Take on BGMS Stock
According to Spark, TipRanks’ AI Analyst, BGMS is a Underperform.
Cyclacel Pharmaceuticals is currently under significant financial strain, marked by operational inefficiencies and a weak financial position, as reflected in its low financial performance score. While the technical indicators suggest a neutral trend, the valuation is unattractive due to its negative P/E ratio and lack of dividend yield. These factors collectively result in a low overall stock score.
To see Spark’s full report on BGMS stock, click here.
More about Bio Green Med Solution
YTD Price Performance: -97.23%
Average Trading Volume: 424,051
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.45M